Further studies showed that this downregulation of MKP-1 mRNA levels started from day 2, a time point preceding the development of dermatitis, and was correlated with an increased expression of p38α in the IMQ-treated skin (Figure S1A in Supplementary Material). The gene discussed is DUSP1; the disease is skin disorder.